Press Releases

The Kidney Cancer Association (KCA) will partner with xCures, the AI-driven medical record aggregator and research company, to bring advanced opportunities for clinical trial participation and treatment to kidney cancer patients. The partnership builds on xCures’ expertise in real-world oncology data to accelerate research advances in kidney cancer. Researchers collaborating with the KCA may access xCures’ database of deidentified, real-time,…

The Kidney Cancer Association (KCA) will present Dr. Nizar M. Tannir with the Nicholas J. Vogelzang Humanitarian Award in honor of his outstanding service and compassion for his patients, his mentorship of colleagues, and his contributions to the KCA and the wider kidney cancer community. Gretchen E. Vaughan, KCA’s President and CEO, will present Dr. Tannir with the Vogelzang Award…

The Kidney Cancer Association is proud to announce an exciting collaboration with the Rare Cancer Research Foundation (RCRF) through its initiative, Pattern.org, that promises to accelerate advancements in the research and treatments of rare kidney cancers. Pattern.org is a patient-driven platform that empowers rare cancer patients to consent to donate their excess, fresh tumor tissue to support scientific research. Pattern.org…

The Kidney Cancer Association (KCA) awarded six grants to six investigators pursuing innovative kidney cancer research across a spectrum of focus areas. The KCA distributed a total of $412,500 in research funds. All the awards support early- to mid-career investigators but three of the six awards supported proposals focused on rare types of kidney cancer. Rare kidney cancer types include…

https://youtube.com/shorts/xkpMPUTmw44?feature=share The Kidney Cancer Association (KCA) welcomes the Wilms Cancer Foundation (WCF) as its newest Affiliate Partner organization. WCF is a charitable organization that supports and represents the needs of children, families & healthcare organizations affected by childhood kidney cancer internationally. “The WCF is delighted to join the KCA Affiliate Program and looks forward to working closely with them to…

https://youtube.com/shorts/DyJx4CpcRYU?feature=share The Kidney Cancer Association (KCA) welcomes the Judy Nicholson Kidney Cancer Foundation (JNF) as the newest affiliate partner organization. Through the Affiliate Program, the KCA can provide expanded support networks for people impacted by kidney cancer, bolster collective grassroots advocacy efforts, and increase opportunities to offer kidney cancer education to the wider community. “This affiliation between the Judy Nicholson…

Salvatore La Rosa with Gretchen E. Vaughan, CEO, at the KCA office in Houston, Texas. The Kidney Cancer Association welcomes Salvatore La Rosa, PhD, a non-profit executive with extensive experience in advancing research programs and treatment pipelines for rare diseases, as its first Chief Scientific Officer (CSO). La Rosa will oversee the KCA’s research initiatives, patient services, and all programs…

The Kidney Cancer Association (KCA) launched an Affiliate Program to bring together like-minded organizations and advocate in partnership for medical advances that improve the lives of people with kidney cancer.   The inaugural group of KCA affiliates are the Chris “CJ” Johnson Foundation, the Chromophobe and Oncocytic Tumor Alliance, and Joey’s Wings Foundation, each of which focus on a rare…

The Kidney Cancer Association presented the inaugural “Kidney Cancer Association Nicholas J. Vogelzang Humanitarian Award” to the KCA’s late co-founder and long-serving board member, Dr. Nicholas J. Vogelzang. Vogelzang, a world-renowned genitourinary oncologist specializing in rare cancer types, died on September 20, 2022 at age 72 following an illness that led him to retire from medical practice and seek hospice…

The Kidney Cancer Association (KCA) awarded seven grants to researchers pursuing projects with the potential to improve kidney cancer treatment and care. “This year we restructured the KCA’s grant program to benefit up-and-coming researchers for whom this type of funding at this point in their careers would make a significant difference,” said Dr. Daniel George, a medical oncologist at the…